Loading
Life sciences · Journal article
Ijid Regions · August 1, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a descriptive epidemiological analysis quantifying the burden of antimicrobial resistance in Iraq in 2021 using Global Burden of Disease data. It identifies bloodstream infections and lower respiratory infections as the leading syndromes associated with AMR-attributable mortality and disability, with specific pathogen contributions reported. The work documents a public health problem requiring coordinated intervention but does not evaluate the effectiveness of any treatment, diagnostic, or policy measure.
Descriptive epidemiological analysis; secondary analysis of Global Burden of Disease data. Population of Iraq in 2021; all deaths and disability from infectious syndromes; no eligibility criteria stated.. Iraq.
Bloodstream infections, lower respiratory infections, peritoneal/abdominal infections, tuberculosis, and urinary tract infections were the leading infectious causes of death in Iraq in 2021. AMR contributed 63.9% of bloodstream infection deaths, 55% of lower respiratory infection deaths, 58% of peritoneal/abdominal infection deaths, 6.9% of tuberculosis deaths, and 62.5% of urinary tract infection deaths. For DALYs, AMR accounted for 60% in bloodstream infections, 55% in lower respiratory infections, 0% in upper respiratory tract infections, 12.5% in diarrhoeal diseases, and 58.9% in peritoneal/abdominal infections.
Mortality rates in Iraq exceeded those of the North Africa and Middle East region for most syndromes, notably urinary tract infections and pyelonephritis.
Clinicians and public health professionals in Iraq should recognize that bloodstream infections and lower respiratory infections are the leading AMR-associated causes of mortality and disability, and that pathogen prevalence patterns (Gram-positive and Gram-negative) reflect regional epidemiology. This finding supports clinical and diagnostic prioritization but does not guide antibiotic choice or evaluate stewardship interventions.
A descriptive burden-of-disease analysis using secondary Global Burden of Disease data, identifying patterns in Iraq but without primary data collection, intervention, or comparative effectiveness evidence.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians and public health professionals in Iraq should recognize that bloodstream infections and lower respiratory infections are the leading AMR-associated causes of mortality and disability, and that pathogen prevalence patterns (Gram-positive and Gram-negative) reflect regional epidemiology. This finding supports clinical and diagnostic prioritization but does not guide antibiotic choice or evaluate stewardship interventions.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background By 2050, antimicrobial resistance (AMR) is projected to become a leading cause of death globally, potentially surpassing cancer. Low- and middle-income countries are particularly vulnerable due to fragile health systems, instability, and economic constraints. Objective This study assessed the burden of AMR in Iraq, identifying the principal infectious syndromes and pathogens contributing to mortality and disability-adjusted life years (DALYs) using Global Burden of Disease data. Results In 2021, the leading infectious causes of death in Iraq were bloodstream infections (BSIs), lower respiratory infections (LRIs), peritoneal and abdominal infections, tuberculosis, and urinary tract infections (UTIs), including pyelonephritis. AMR contributed 63.9%, 55%, 58%, 6.9%, and 62.5% of these deaths, respectively. The syndromes responsible for DALYs were BSIs, LRIs, upper respiratory tract infections, diarrhoeal diseases, and peritoneal and abdominal infections; AMR accounted for 60%, 55%, 0%, 12.5%, and 58.9% of DALYs, respectively. Conclusion The principal pathogens associated with deaths were Streptococcus pneumoniae (12.9%), Staphylococcus aureus (12.4%), Klebsiella pneumoniae (9.9%), Acinetobacter baumannii (8.1%), and Pseudomonas aeruginosa (7.2%). Mortality rates exceeded those of the North Africa and Middle East region NAME for most syndromes, notably UTIs and pyelonephritis. Conclusion AMR represents a substantial burden on mortality and disability in Iraq with the BSI and LRIs were reported at the highest. Coordinated national interventions are required in Iraq, including strengthened diagnostics, workforce training, public awareness, and regulatory enforcement.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.